List of Top Pharma Sector Stocks in India (2025)

India has solidified its position as the world’s largest supplier of generic medicines, fulfilling approximately 20% of global generic drug exports. The nation’s pharmaceutical exports reached $27 billion in 2023, a significant increase from $19 billion in 2018, growing at an annual rate of 8%. Domestically, the Indian pharmaceutical market is projected to expand by 8.2% in 2025, reaching ₹2.38 lakh crore. Given this robust growth and resilience, Indian pharmaceutical companies continue to attract investors. So, let’s understand some of the popular Indian pharma companies, best pharma stocks in India and what factors are shaping the industry.
List of Top Pharma Stocks in India
The pharma sector has contributed significantly to India’s economic growth as one of the top 10 sectors in reducing the trade deficit and attracting Foreign Direct Investment (FDI). Here’s a list of the top pharmaceutical stocks in India:
symbol | Company | ticker | slug | Sector | Market Price | 52W High | 52W Low | Market Cap (Cr.) | PE Ratio | Industry PE | PB Ratio | Div. Yield (%) | ROE (%) | 1YReturns | 3YReturns | 5YReturns | Market Cap Label | Industry Group | Industry | Sub Industry | percentageChange |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABOT | Abbott India Ltd | ABBOTINDIA | /stocks/abbott-india-ABOT | Pharmaceuticals | 30,005.00 | 31,898.95 | 25,325.00 | 63,758.53 | 53.08 | 48.27 | 17.24 | 1.37 | 34.88 | 15.68 | 79.65 | 69.47 | Midcap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | -0.15 |
BLUEJ | Blue Jet Healthcare Ltd | BLUEJET | /stocks/blue-jet-healthcare-BLUEJ | Pharmaceuticals | 723.30 | 968.30 | 347.60 | 12,546.75 | 76.62 | 48.27 | 14.84 | 0.14 | 21.45 | 90.37 | 74.96 | 74.96 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | -0.35 |
GLAX | GlaxoSmithKline Pharmaceuticals Ltd | GLAXO | /stocks/glaxosmithkline-pharmaceuticals-GLAX | Pharmaceuticals | 2,743.30 | 3,148.00 | 1,921.00 | 46,473.16 | 78.77 | 48.27 | 26.14 | 1.17 | 33.53 | 36.21 | 79.53 | 90.84 | Midcap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | 0.02 |
GLS | Alivus Life Sciences Ltd | ALIVUS | /stocks/glenmark-life-sciences-GLS | Pharmaceuticals | 1,106.10 | 1,335.10 | 755.95 | 13,564.01 | 28.81 | 48.27 | 5.82 | 2.03 | 21.07 | 32.73 | 146.40 | 47.78 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | 0.16 |
GUJTH | Gujarat Themis Biosyn Ltd | GUJTHEM | /stocks/gujarat-themis-biosyn-GUJTH | Pharmaceuticals | 264.15 | 390.00 | 192.35 | 2,663.11 | 45.02 | 48.27 | 13.22 | 1.36 | 33.75 | 0.03 | 349.03 | 990.63 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | 1.25 |
JSLL | Jeena Sikho Lifecare Ltd | JSLL | /stocks/jeena-sikho-lifecare-JSLL | Pharmaceuticals | 2,179.70 | 2,498.60 | 997.50 | 5,418.77 | 78.29 | 48.27 | 28.19 | 0.22 | 43.52 | 107.40 | 2,356.00 | 2,163.32 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | -0.45 |
PROR | Procter & Gamble Health Ltd | PGHL | /stocks/procter-and-gamble-health-PROR | Pharmaceuticals | 5,024.00 | 5,850.00 | 4,639.25 | 8,339.53 | 41.49 | 48.27 | 15.49 | 5.18 | 31.18 | 5.90 | 14.48 | 23.30 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | -0.60 |
ROX | Remedium Lifecare Ltd | REMLIFE | /stocks/roxy-exports-ROX | Pharmaceuticals | 1.73 | 17.80 | 1.21 | 154.85 | 4.73 | 48.27 | 3.60 | 0.00 | 122.77 | -89.36 | 104.49 | 1,088.84 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | -1.73 |
SUPRI | Supriya Lifescience Ltd | SUPRIYA | /stocks/supriya-lifescience-SUPRI | Pharmaceuticals | 638.10 | 842.00 | 330.00 | 5,135.61 | 43.11 | 48.27 | 6.30 | 0.13 | 15.73 | 73.09 | 81.38 | 63.26 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | -2.08 |
SUVH | Cohance Lifesciences Limited | SUVENPHAR | /stocks/suven-pharmaceuticals-SUVH | Pharmaceuticals | 1,060.20 | 1,360.00 | 598.00 | 26,988.98 | 89.88 | 48.27 | 13.16 | 0.00 | 15.86 | 60.37 | 87.23 | 637.27 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Pharmaceuticals | Pharmaceuticals | 0.61 |
Disclaimer: Please note that the above table is for educational purposes only, and is not recommendatory. Please do your own research or consult your financial advisor before investing. The data is derived from Tickertape Stock Screener and is subject to real-time updates.
Note: The data in the list of pharma stocks, with the top pharma share prices, in India is dynamic and subject to real-time changes. This data was derived from Tickertape Stock Screener using the following criteria:
- Sector: Pharmaceuticals
- 5Y Average Net Profit Margin: Set Lower Limit to 0 (Positive)
- 5Y Average Return on Investment: Sort from Highest to Lowest
🚀 Pro Tip: You can use Tickertape’s Stock Screener to research and evaluate stocks with over 200+ filters and parameters.
Top Pharma Companies in India: An Overview
Here is the overview of the top 10 pharma stocks in India on the medical share price list. The following stocks are on an educational pharma stocks list curated above of the best pharmaceutical stocks in India:
Glenmark Life Sciences Ltd
Glenmark Life Sciences Ltd, a subsidiary of Glenmark Pharmaceuticals, was established in 2011. The company specialises in manufacturing and supplying Active Pharmaceutical Ingredients (APIs) to leading pharmaceutical companies worldwide. The best pharma stock in India has a strong market presence in the API sector, providing high-quality products and services to a global clientele.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn (GTBL), established in December 1981 as a public limited company, was promoted by Kantilal Shah and the Gujarat Industrial Investment Corporation. Initially, the company focused on producing the antibiotic erythromycin.
Blue Jet Healthcare Ltd
Blue Jet Healthcare Limited began as Jet Chemicals Private Limited in Mumbai on 7 December 1968. Among the top-performing pharma stocks specialising in pharmaceutical and healthcare ingredients and intermediates, Blue Jet Healthcare provides niche products for both innovator pharmaceutical companies and multinational generic pharmaceutical firms.
GlaxoSmithKline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Ltd (GSK India), a subsidiary of GlaxoSmithKline plc, was established in 1924. The company is a leading healthcare provider with a strong presence in pharmaceuticals and vaccines in India. This top pharmaceutical company in India focuses on innovative healthcare solutions and robust R&D initiatives.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Limited, a leading ayurvedic healthcare company in India, is headquartered in Zirakpur, Punjab. It was initially incorporated as ‘Jeena Sikho Lifecare Private Limited’ on 29th May 2017, under the Companies Act, 2013. Later, following a Shareholders’ Resolution at an Extraordinary General Meeting on 25th June 2021, the company transitioned to a public limited entity and was renamed ‘Jeena Sikho Lifecare Limited.’
However, if you’re confused about which stocks to pick, you can explore smallcases:
- smallcases are readymade model portfolios of stocks/ETFs, that are based on a theme idea or strategy
- They’re created and managed by SEBI-registered investment experts (also known as smallcase managers)
- smallcase offers over 500+ stock portfolios, created by 200+ managers
Here are a few popular smallcases among new investors:
Disclosures for aforementioned smallcases
What are Pharma Stocks in India?
Pharma stocks in India are the stocks of companies that operate in India pharmaceutical industry, which includes the research, development, manufacturing, and distribution of drugs and medicines. The best pharma companies are involved in producing various types of medicines, such as prescription drugs, over-the-counter medicines, and generic drugs.
Union Budget 2025-26 Update on Healthcare Sector
The budgetary allocations for FY 2025-26 presented by Finance Minister Nirmala Sitharaman for the healthcare sector is ₹98,311 cr., reflecting a 10.11% increase from the previous year. Here are some pharmaceutical initiatives that were included in the announcement.
- Full customs duty exemption on 36 life-saving drugs for cancer and other chronic/rare diseases.
- Six life-saving medicines to attract a concessional 5% customs duty.
- 37 additional medicines and 13 new assistance programmes added under the Patient Assistance Programme.
Types of Pharma Stocks in India
In India, the pharma sector share list is divided into three categories based on the market capitalisation of the leading pharma companies in India listed on the NSE:
Large-Cap Pharma Stocks
Large-cap pharma stocks in a pharmacy stock list represent the largest pharmaceutical companies India, with a market capitalisation of more than Rs. 20,000 cr. These top medical companies in India generally have a strong brand presence, diversified product portfolios, and significant R&D capabilities. Some examples of large-cap pharma stocks in India include Sun Pharma, Dr. Reddy’s Laboratories, and Cipla.
Mid Cap Pharma Stocks
Mid cap pharma stocks in a medical share list consist of medium-sized pharmaceutical companies with a market capitalisation between Rs. 5,000 and Rs. 20,000 cr. These companies might have a more focused product portfolio and less diversified revenue streams compared to large-cap companies. Examples of mid-cap pharma stocks in India include Torrent Pharma, Alkem Laboratories, and Biocon.
Small Cap Pharma Stocks
Small cap pharma stocks include smaller pharmaceutical companies with a market capitalisation of less than Rs. 5,000 cr. These companies, including pharma penny stocks, often have niche product portfolios and limited R&D capabilities compared to larger companies. Examples of small-cap pharma stocks in India include Aarti Drugs, Suven Life Sciences, and Granules India.
What is the Pharma NIFTY Index?
The Pharma NIFTY Index is an index of the National Stock Exchange of India (NSE) that comprises the top 10 pharmaceutical companies listed on the exchange. These top pharma companies India are selected based on market capitalisation, liquidity, and other factors. The index provides a benchmark for the overall performance of the pharmaceutical sector in India.
When the Pharma NIFTY Index rises, it indicates that the pharmaceutical sector is performing well. Conversely, a decline in the index suggests underperformance. This index is a common indicator used by investors and analysts to track the performance of the Indian pharmaceutical industry.
Features of Pharma Company Stocks in India
Investors eyeing the pharmaceutical sector in India should be aware of distinctive features that characterise pharma company stocks.
- Regulatory Environment: Pharma stocks, including the Indian healthcare stocks, are significantly influenced by regulatory dynamics. Stay informed about updates from regulatory bodies like the Food and Drug Administration (FDA) and the Pharmaceuticals and Medical Devices Agency (PMDA).
- R&D Pipeline: The Research and Development pipeline of a pharmaceutical company is a critical aspect. Evaluate the company’s investment in developing new drugs and the potential impact on its market position.
- Market Competition: The level of competition within the Indian pharmaceutical market is intense. Best pharmaceutical companies India with a diversified portfolio and effective strategies to navigate market competition may present better resilience.
- Global Presence: Many Indian pharmaceutical companies have a global footprint. Assess the geographical reach of the best pharma company in India, as it can impact revenue streams and vulnerability to international market fluctuations.
- Patent Expiry: The expiration of patents for key drugs can significantly impact a pharma company’s financials. Stay informed about patent expiry dates to anticipate potential shifts in the market landscape.
Benefits of Investing in Pharma Stocks in India
There are several benefits to investing in Indian pharma stocks, which have a thriving and rapidly growing pharmaceutical industry. Here are some of the key benefits:
- Steady Demand: Pharma stocks are known for their steady demand, as people require medicines regardless of the economic climate. As a result, pharma stocks are considered relatively defensive and can provide investors a stable source of income.
- Strong Growth Potential: The Indian pharma industry is growing rapidly, with the government actively promoting the sector through various initiatives. The industry is expected to grow at 12-14% CAGR providing significant growth potential for investors.
- High Profitability: Pharmaceutical industry stocks tends to have high-profit margins due to the significant investment required for research and development. This high-profit margin might translate into higher returns for investors.
- Dividends: Many pharmaceutical companies have a strong track record of paying dividends to shareholders. This can provide a source of passive income for investors searching for pharma stocks for growth.
Risks of Investing in Pharma Stocks in India
Investing always involves risk, and pharmaceutical stocks are no different. Understanding key risk factors is crucial when selecting the best pharma stocks India.
- Regulatory Environment: The pharmaceutical industry operates under heavy regulations, and changes in government policies, especially regarding price controls and exports, can directly affect pharma stocks with high returns historically.
- US Market: For many major pharmaceutical companies, the US market is pivotal for selling generic drugs. Investors in these companies need to be vigilant about regulatory risks, especially considering the historical pricing pressure in the US market. Recent indications suggest a potential easing of pricing pressure on the best pharma stocks 2025 for long-term, but ongoing scrutiny from the United States Food and Drug Administration on pharma companies in India’s manufacturing units poses a risk, with the issuance of warning letters being a significant negative factor even in the case of the best medicine company in India.
- Currency Fluctuations and Operational Risks: The export-oriented nature of the Indian pharma industry in India makes it susceptible to currency fluctuations, directly impacting revenues and the bottom line. Additional risks include variations in raw material and packaging costs, higher freight rates, and disruptions in the supply chain.
How to Identify the Best Pharma Stocks for Investing?
Selecting the best pharmaceutical company in India from pharma sector stocks lists requires careful analysis and consideration of various factors. Here are some steps you might take to identify the top pharma company in India:
- Assess Financial Health: You should examine the financial health of top pharma shares in India by reviewing their earnings reports, debt levels, and cash flow. A company with stable earnings, manageable debt, and strong cash flow typically indicates financial robustness and stability.
- Evaluate Drug Pipeline: It’s important to scrutinise the company’s pipeline of drugs. A diverse and promising pipeline indicates resilience in the face of industry changes and the potential for future growth.
- Consider Regulatory Environment: Approvals and compliance are critical factors influencing the success of pharmaceutical companies. Staying informed about the regulatory environment can help you anticipate potential challenges and opportunities for the company.
- Stay Informed on Industry Trends: Keeping abreast of pharma stocks market trends, breakthroughs, and global healthcare dynamics can significantly impact your investment decisions. Market competition and geopolitical factors play a major role in the pharmaceutical sector.
- Analyse Historical Performance: You should dive into the historical performance of the stocks in the list of pharmaceutical companies in India under consideration. Assess past trends, volatility, and how stocks have responded to market shifts.
Who Should Explore in Pharma Stocks?
Investing in pharmaceutical stocks can be attractive for various types of investors:
- Long-Term Investors: The best pharma company stocks in India for long term often offer stability and long-term growth potential. If you have a long-term investment horizon, you can benefit from the consistent demand for healthcare products and the potential for research and development to drive future growth.
- Income-Oriented Investors: Many pharmaceutical companies have a history of distributing dividends to their shareholders. If you are an income-focused investor seeking a regular stream of dividend income, pharmaceutical stocks might be appealing.
- Risk-Averse Investors: Relative to some other sectors, pharmaceuticals tend to experience less volatility. If you prioritise stability and lower risk, you might consider including pharmaceutical stocks, or medicine stocks, in your portfolio.
- Healthcare Sector Enthusiasts: If you have a strong interest in the healthcare sector, understand its dynamics, and believe in its long-term growth prospects, you may find pharmaceutical stocks particularly appealing.
As always, you should do your own research and/or consult your financial advisor before investing. Thorough analysis and professional guidance can help ensure that your investment choices align with your financial goals and risk tolerance.
Factors Affecting Investments in Pharma Stocks
Factors Impacting Pharmaceuticals Sector Stocks are:
- Success of Clinical Trials and Drug Pipeline: The outcomes of clinical trials heavily influence growth potential pharma stocks, serving as indicators of potential revenue growth.
- Approvals and Regulatory Landscape: Regulatory processes and approvals play a crucial role in the future of pharma stocks and shaping drug commercialisation timelines, thereby affecting stock prices.
- Pricing Pressures and Healthcare Policies: Changes in pricing regulations, reimbursement policies, and healthcare cost reduction efforts have significant implications for sector stock performance.
- Patent Expirations and Generic Competition: Patents’ expiration and generic competition’s emergence affect company profitability and stock performance.
- Market and Economic Dynamics: Market conditions, economic indicators such as GDP growth, interest rates, inflation, and investor sentiment all impact stock prices within the pharmaceutical sector.
Factors to Consider Before Investing in Pharma Companies
Before investing in Indian pharma stocks, it’s important to consider several key factors beyond just pharma company share prices. Here are some essential considerations:
- Domestic and Global Demand: The demand for pharmaceuticals is influenced by various factors, such as an ageing population, increasing healthcare spending, and the prevalence of diseases. To determine if the pharma sector growth in India, you should analyse the demographic trends and healthcare needs that drive the market.
- Research and Development Investments: It’s crucial to evaluate a company’s R&D investments and pipeline to determine if they are investing in the right areas. A strong pipeline of potential new products indicates a company’s commitment to innovation and future growth.
- Regulatory Environment and Government Policies: It’s important to stay updated on regulatory changes and procedures affecting the industry and specific companies. Understanding the regulatory landscape can help you anticipate challenges and opportunities within the sector.
- Intellectual Property Rights and Patent Expirations: Patents provide big and small pharma companies in India with exclusive rights to manufacture and sell a drug for a set period. Evaluating a company’s patent portfolio and the timing of patent expirations is essential to determine the potential impact on revenue. Patent expirations can lead to increased competition from generic drugs, affecting a company’s market share and profitability.
- Competition and Mergers and Acquisitions: Evaluating a company’s competitive landscape, growth strategies, and recent mergers or acquisitions can provide insights into its potential for long-term success.
To Wrap It Up…
In conclusion, the Indian stock market has demonstrated resilience and growth potential in 2023. As we move further into the year, several pharma companies have garnered investor interest and shown promising performance. Investing in popular stocks through smallcase could be an effective way for investors to capitalise on growth opportunities. With Pharma Tracker smallcase, you can efficiently track and invest in pharma companies listed in NSE.
Frequently Asked Questions on Pharma Stocks
The top 5 pharma stocks in India based on their 5-year ROI are:
-Alivus Life Sciences Ltd
-Gujarat Themis Biosyn Ltd
-Blue Jet Healthcare Ltd
-GlaxoSmithKline Pharmaceuticals Ltd
-Jeena Sikho Lifecare Ltd
Note: The data on this pharma sector stock list is for education purposes and is not recommendatory in nature.
To invest in pharma sector stocks, open a brokerage account, research pharmaceutical companies, fund your account, place buy orders for selected stocks, and monitor your investments.
The suitability of investing in pharma stocks depends on market conditions and your financial goals. Evaluate factors like the pharmaceutical industry’s performance and company-specific data, and consult a financial advisor for personalised guidance.
When evaluating pharmaceutical stocks, look for companies with a strong pipeline, a track record of success, and a focus on unmet medical needs.
For some, pharma stocks can be risky due to the long and expensive drug development process. However, they can also potentially be a good long-term investment for investors who are willing to take on some risk. Investors should do their own research or consult their financial advisor before investing.
Discover Other Collections:
Keep yourself informed and up-to-date on a variety of thematic sectors by reading the articles below:
Indices and Market Movers
Stocks Under Budget
If you are looking for stocks under a particular price range, here’s the collection of stocks under a specifc budget: